Continuation versus Interruption of Oral Anticoagulation during TAVI Back February 17, 2025 by admin Document https://www.nejm.org/doi/full/10.1056/NEJMoa2407794?query=TOC&ssotoken=U2FsdGVkX18N2NfOQJaQ5x%2FQ5vThzxb4u29SLd%2BdfgiO9VirpxebjbQiQsxDkrAXNJACRrhlNK4waOZRgTMe23x%2FUl8xdxOh6Xaf6VphU7X85GVTEh398sV6%2FhlDJkW3IutlJD84bXyW%2BQaRABQj9CDemgluiQdvlbzN6lUGGyGTep96OSwI20B0P0AQ8mdFHT7YutojHkT1e0JN6Rcu2g%3D%3D&cid=DM2384078_Non_Subscriber&bid=-1519047293 Metadata SubjectContinuation versus Interruption of Oral Anticoagulation during TAVITypeArticleTitleContinuation versus Interruption of Oral Anticoagulation during TAVILanguageEnglish Continue browsing Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity Population based survey of chronic noncommunicable diseases at gilgel gibe field Research center, southwest Ethiopia Back to items list